Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

Accentrix is indicated in adults for: The treatment of neovascular (wet) age-related macular degeneration (AMD), the treatment of visual impairment due to diabetic macular oedema (DME), the treatment of proliferative diabetic retinopathy (PDR), the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (RVO), the treatment of visual impairment due to choroidal neovascularization (CNV).
Accentrix is indicated in preterm infants for: The treatment of retinopathy of prematurity (ROP) with zone I (stage 1+, 2+, 3 or 3+), zone II (stage 3+) or AP-ROP (aggressive posterior ROP) disease.

Accentrix Indications/Uses

ranibizumab

Manufacturer:

Novartis

Distributor:

DKSH